Phosphorylation of signal transducer and activator of transcription 1 reduces bortezomib-mediated apoptosis in cancer cells

The potent and selective proteasome inhibitor bortezomib has shown remarkable antitumor activity and is now entering clinical trials for several cancers. However, the molecular mechanisms by which bortezomib induces cytotoxicity in ovarian cancer cells still remain unclear. In this study, we show th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kao, C, Chao, A, Tsai, C L, Lin, C Y, Chuang, W C, Chen, H W, Yen, T C, Wang, T H, Lai, C H, Wang, H S
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3734825/
https://ncbi.nlm.nih.gov/pubmed/23449448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2013.38
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados